Carlos H. Barcenas - M. D. Anderson Cancer Center, The University of Texas

Omer Abdelgadir, Maryam R Hussain, Kelseanna Hollis-Hansen,Carlos H Barcenas,Yong-Fang Kuo, Celette S Skinner, Lindsay G Cowell, Sarah E Messiah, David S Lopez

Cancersno. 10 (2025)

Cited0Views0WOSBibtex

Aromatase Inhibitors and Their Connection to Autoimmunity

Savannah Bowman,Carlos H Barcenas,Huifang Lu

Journal of Cancer Immunologyno. 1 (2024): 40-43

Cited0Views0Bibtex

Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination with Trastuzumab Deruxtecan in Patients with HER2 Low/ultra-Low/null Metastatic Breast Cancer

Toshiaki Iwase,Senthil Damodaran,Angela Marx,Funda Meric-Bernstam,Debashish Tripathy,Carlos Hernando Barcenas,Jangsoon Lee,Naoto Tada Ueno

Journal of Clinical Oncologyno. 16_suppl (2024): TPS1120-TPS1120

Cited0Views0Bibtex

Abstract PO3-19-10: Phase 1b study of EZH1/2 inhibitor valemetostat in combination with trastuzumab deruxtecan in subjects with HER2 low/ultra-low/null metastatic breast cancer

Senthil Damodaran,Toshiaki Iwase,Angela Marx,Jie Willey,Funda Meric-Bernstam,Debu Tripathy,Carlos Barcenas,Jangsoon lee,Naoto Ueno

Cancer Researchno. 9_Supplement (2024): PO3-19

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn